Although we adjusted BMI for adiposity in detecting the association of FTO polymorphism with T2D risk, we cannot rule out the possibility of residual confounding of obesity, because the alternative measures (such as DEXA fat mass) of adiposity were not available in this study. This evidence concerns the gene FTO and Obesity.